Author:
Hogan Kathryn M.,Lagoo Anand Shreeram,Inamdar Kedar V.
Publisher
Springer International Publishing
Reference96 articles.
1. Lieu D. Cytopathologist-performed ultrasound-guided fine-needle aspiration and core-needle biopsy: a prospective study of 500 consecutive cases. Diagn Cytopathol. 2008;36(5):317–24.
2. Florentine BD, Staymates B, Rabadi M, Sarda N, Barstis J, Black A. Cost savings associated with the use of fine-needle aspiration biopsy (FNAB) for the diagnosis of palpable masses in a community hospital-based FNAB clinic. Cancer. 2006;107(9):2270–81.
3. Young NA, Moriarty AT, Haja JC, Wilbur DC. Fine-needle aspiration biopsy of lymphoproliferative disorders–interpretations based on morphologic criteria alone: results from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Arch Pathol Lab Med. 2006;130(12):1766–71.
4. Swerdlow SH, O. World Health, and C. International Agency for Research on, WHO classification of tumours of haematopoietic and lymphoid tissues: Lyon, International Agency for Research on Cancer; 2017.
5. Scallon BJ, Snyder LA, Anderson GM, Chen Q, Yan L, Weiner LM, et al. A review of antibody therapeutics and antibody-related technologies for oncology. J Immunother. 2006;29(4):351–64.